A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09979-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Samane Teymouri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Nanoparticles, Anti-Bacterial Agents, Bacteriophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 129 Literaturangaben.
Abstract (Originalsprache)
In the current era of antibiotic resistance, researchers are exploring alternative ways to treat bacterial infections that are resistant to multiple drugs. Acinetobacter baumannii (A. baumannii) is a bacterium that is commonly encountered in clinical settings and is known to be resistant to several drugs. Due to the increase in drug-resistant infections caused by this bacteria, there is an urgent need to investigate alternative treatment options such as phage therapy and combination therapy. Despite the success of phages in some cases, there are some limitations in their clinical application that can be overcome by combining phages with other substrates such as nanoparticles to improve their function. The integration of nanotechnology with phage therapy against A. baumannii promises to overcome antibiotic resistance. By exploiting the targeted delivery and controlled release capabilities of nanoparticles, we can enhance the therapeutic potential of phages while minimizing their limitations. Continued research in this field will undoubtedly pave the way for more effective and precise treatments against A. baumannii infections and provide hope in the fight against antibiotic-resistant bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. m-pourhajibagher@sina.tums.ac.ir.
- Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran. m-pourhajibagher@sina.tums.ac.ir.
- Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. abahador@sina.tums.ac.ir.
- Fellowship in Clinical Laboratory Sciences, BioHealth Lab, Tehran, Iran. abahador@sina.tums.ac.ir.
Zitieren
APA
Teymouri, S., Pourhajibagher, M., & Bahador, A. (2024). A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09979-4
Vancouver
Teymouri S, Pourhajibagher M, Bahador A. A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09979-4
BibTeX
@article{Teymouri2024,
author = {Teymouri, Samane and Pourhajibagher, Maryam and Bahador, Abbas},
title = {A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09979-4}
}
EUVIMED